"skipMainNavigation"
Search
Quick Search in Journals
Quick Search anywhere
Advanced Search
Radiology
The logo for the journal RadioGraphics
The logo for the journal Radiology: Imaging Cancer
The logo for the journal Radiology: Cardiothoracic Imaging
The logo for the journal Radiology: Artificial Intelligence
Menu
Previous
Next
Original Research

Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer

Published Online:Sep 10 2019https://doi.org/10.1148/radiol.2019190687

Abstract

While overall diagnostic performance in local staging of patients with prostate cancer at intermediate to high risk was similar, use of a gallium 68 (68Ga)-labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane antigen (PSMA) (68Ga-PSMA-11) PET/MRI may improve the sensitivity of multiparametric MRI for the detection of extracapsular disease, at the cost of a slightly reduced specificity.

Background

Recent studies have reported the additive value of combined gallium 68 (68Ga)-labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane antigen (PSMA) (hereafter called 68Ga-PSMA-11) PET/MRI for the detection and localization of primary prostate cancer compared with multiparametric MRI.

Purpose

To compare the diagnostic accuracy and interrater agreement of multiparametric MRI and 68Ga-PSMA-11 PET/MRI for the detection of extracapsular extension (ECE) and seminal vesicle infiltration (SVI) in patients with prostate cancer.

Materials and Methods

Retrospective analysis of 40 consecutive men who underwent multiparametric MRI and 68Ga-PSMA-11 PET/MRI within 6 months for suspected prostate cancer followed by radical prostatectomy between April 2016 and July 2018. Four readers blinded to clinical and histopathologic findings rated the probability of ECE and SVI at multiparametric MRI and PET/MRI by using a five-point Likert-type scale. The prostatectomy specimen served as the reference standard. Accuracy was assessed with a multireader multicase analysis and by calculating reader-average areas under the receiver operating characteristics curve (AUCs), sensitivity, and specificity for ordinal and dichotomized data in a region-specific and patient-specific approach. Interrater agreement was assessed with the Fleiss multirater κ.

Results

For multiparametric MRI versus PET/MRI in ECE detection, respectively, AUC, sensitivity, and specificity in the region-specific analysis were 0.67 and 0.75 (P = .07), 28% (21 of 76) and 47% (36 of 76) (P = .09), and 94% (529 of 564) and 90% (509 of 564) (P = .007). For the patient-specific analysis, AUC, sensitivity, and specificity were 0.66 and 0.73 (P = .19), 46% (22 of 48) and 69% (33 of 48) (P = .04), and 75% (84 of 112) and 67% (75 of 112) (P = .19), respectively. For multiparametric MRI versus PET/MRI in SVI detection, respectively, AUC, sensitivity, and specificity of the region-specific analysis were 0.66 and 0.74 (P = .21), 35% (seven of 20) and 50% (10 of 20) (P = .25), and 98% (295 of 300) and 94% (282 of 300) (P < .001). For the patient-specific analysis, AUC, sensitivity, and specificity were 0.65 and 0.79 (P = .25), 35% (seven of 20) and 55% (11 of 20) (P = .20), and 98% (137 of 140) and 94% (131 of 140) (P = .07), respectively. Interrater reliability for multiparametric MRI versus PET/MRI did not differ for ECE (κ, 0.46 vs 0.40; P = .24) and SVI (κ, 0.23 vs 0.33; P = .39).

Conclusion

Our results suggest that gallium 68 (68Ga)-labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane antigen (PSMA) (68Ga-PSMA-11) PET/MRI and multiparametric MRI perform similarly for local staging of prostate cancer in patients with intermediate-to-high-risk prostate cancer. The increased sensitivity of 68Ga-PSMA-11 PET/MRI for the detection of extracapsular disease comes at the cost of a slightly reduced specificity.

© RSNA, 2019

Download as PowerPoint

References

  • 1. Mikel Hubanks J, Boorjian SA, Frank I, et al. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. Urol Oncol 2014;32(1):26.e1–26.e7.
    Google Scholar
  • 2. Partin AW, Borland RN, Epstein JI, Brendler CB. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 1993;150(1):142–146; discussion 146–148.
    Medline Google Scholar
  • 3. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017;71(4):618–629.
    Medline Google Scholar
  • 4. Martini A, Gupta A, Lewis SC, et al. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int 2018;122(6):1025–1033.
    Medline Google Scholar
  • 5. Johnson LM, Turkbey B, Figg WD, Choyke PL. Multiparametric MRI in prostate cancer management. Nat Rev Clin Oncol 2014;11(6):346–353.
    Medline Google Scholar
  • 6. Ahmed HU, Arya M, Freeman A, Emberton M. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 2012;13(11):e509–e517.
    Medline Google Scholar
  • 7. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med 2018;378(19):1767–1777.
    Medline Google Scholar
  • 8. Verma S, Choyke PL, Eberhardt SC, et al. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology 2017;285(2):343–356.
    Google Scholar
  • 9. de Rooij M, Hamoen EHJ, Witjes JA, Barentsz JO, Rovers MM. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. Eur Urol 2016;70(2):233–245.
    Medline Google Scholar
  • 10. Hoeks CM, Barentsz JO, Hambrock T, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011;261(1):46–66.
    Google Scholar
  • 11. Donati OF, Mazaheri Y, Afaq A, et al. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 2014;271(1):143–152.
    Google Scholar
  • 12. Afshar-Oromieh A, Zechmann CM, Malcher A, et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 2014;41(1):11–20.
    Medline Google Scholar
  • 13. Eissa A, Elsherbiny A, Coelho RF, et al. The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature. Minerva Urol Nefrol 2018;70(5):462–478.
    Medline Google Scholar
  • 14. Schwenck J, Rempp H, Reischl G, et al. Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT. Eur J Nucl Med Mol Imaging 2017;44(1):92–101.
    Medline Google Scholar
  • 15. Hicks RM, Simko JP, Westphalen AC, et al. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology 2018;289(3):730–737.
    Google Scholar
  • 16. Park SY, Zacharias C, Harrison C, et al. Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer. Radiology 2018;288(2):495–505.
    Google Scholar
  • 17. Rhee H, Thomas P, Shepherd B, et al. Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. J Urol 2016;196(4):1261–1267.
    Medline Google Scholar
  • 18. Burger IA, Müller J, Donati OF, et al. 68Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU. J Nucl Med 2019;60(8):1118–1123.
    Medline Google Scholar
  • 19. Eiber M, Weirich G, Holzapfel K, et al. Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. Eur Urol 2016;70(5):829–836.
    Medline Google Scholar
  • 20. Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69(1):16–40.
    Medline Google Scholar
  • 21. D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280(11):969–974.
    Medline Google Scholar
  • 22. Huang SC, Savic D, Yang J, Shrestha U, Seo Y. The effect of magnetic field on positron range and spatial resolution in an integrated whole-body time-of-flight PET/MRI system. 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC). Seattle, Wash: IEEE; 2014; 1–4.
    Google Scholar
  • 23. Fendler WP, Eiber M, Beheshti M, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging 2017;44(6):1014–1024.
    Medline Google Scholar
  • 24. Gallas BD, Pennello GA, Myers KJ. Multireader multicase variance analysis for binary data. J Opt Soc Am A Opt Image Sci Vis 2007;24(12):B70–B80.
    Medline Google Scholar
  • 25. Gallas BD, Bandos A, Samuelson FW, Wagner RF. A Framework for Random-Effects ROC Analysis: Biases with the Bootstrap and Other Variance Estimators. Commun Stat Theory Methods 2009;38(15):2586–2603.
    Google Scholar
  • 26. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997;53(2):567–578.
    Medline Google Scholar
  • 27. Vanbelle S. Comparing dependent kappa coefficients obtained on multilevel data. Biom J 2017;59(5):1016–1034.
    Medline Google Scholar
  • 28. Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls. RadioGraphics 2018;38(1):200–217.
    Google Scholar
  • 29. Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 2010;37(2):301–309.
    Medline Google Scholar
  • 30. Mehralivand S, Shih JH, Harmon S, et al. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI. Radiology 2019;290(3):709–719.
    Google Scholar
  • 31. Krishna S, Lim CS, McInnes MDF, et al. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer. J Magn Reson Imaging 2018;47(1):176–185.
    Medline Google Scholar
  • 32. Soylu FN, Peng Y, Jiang Y, et al. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 2013;267(3):797–806.
    Google Scholar
  • 33. Thalgott M, Düwel C, Rauscher I, et al. One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer. J Nucl Med 2018;59(12):1850–1856.
    Medline Google Scholar
  • 34. Fendler WP, Schmidt DF, Wenter V, et al. 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer. J Nucl Med 2016;57(11):1720–1725.
    Medline Google Scholar
  • 35. von Klot CJ, Merseburger AS, Böker A, et al. 68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer. Nucl Med Mol Imaging 2017;51(4):314–322.
    Medline Google Scholar

Article History

Received: Mar 26 2019
Revision requested: May 16 2019
Revision received: July 24 2019
Accepted: Aug 5 2019
Published online: Sept 10 2019
Published in print: Nov 2019